TruScreen Announces New Chairman

NZX and Media Release 4 October 2018
NZX Limited
WELLINGTON
TruScreen Announces New Chairman

TruScreen Limited (NZAX: TRU)
Cervical cancer technology company, TruScreen Limited (NZAX:TRU, or “the Company”) announces
that Mr Robert Hunter has been replaced by Mr Anthony (Tony) Ho as Chairman of the company.
Mr Hunter who was the founder and initial Chairman of TruScreen, recently announced his decision
to step down from the chairmanship at the 2018 AGM.
The board is pleased to advise that Mr Tony Ho has been appointed as the replacement Chairman.
Tony is an experienced company director with over 25 years’ experience in diverse industries,
including resources, services, biotech, consumer goods wholesale and retail. He holds a Commerce
degree from the University of New South Wales, Sydney. He is a Chartered Accountant and a fellow
of the Australian Institute of Company Directors, Chartered Institute of Secretaries and
Administrators and the Governance Institute of Australia.
Mr Hunter who remains a significant shareholder was re-elected to the board at the recent AGM and
will continue to serve as a non-executive director.


Martin Dillon
CEO

-ENDS-


For more information visit www.truscreen.com


Contact
Martin Dillon
TruScreen Chief Executive Officer
Email: martindillon@truscreen.com

About TruScreen:
TruScreen’s real time cervical cancer technology
utilises a digital wand which is placed on the
surface of the cervix to measure electrical and
optical signals from the surrounding tissue. A
sophisticated proprietary algorithm framework
distinguishes between normal and abnormal
(cancerous and precancerous) tissue to identify
precancerous change, or cervical intraepithelial
neoplasia (CIN). A Single Use Sensor (SUS) is used
for each patient to protect against cross-infection.